HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
- £8.15m
- £10.57m
REG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 13/06/2025
AnnouncementREG - Hemogenyx Pharma Plc - Placing to Raise £451,250 and Director’s Dealing
AnnouncementREG - Hemogenyx Pharma Plc - Second Patient Passes Initial Safety Tests
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Hemogenyx Pharma Plc - Result of AGM
AnnouncementRCS - Hemogenyx Pharma Plc - Pediatric Amendment to Clinical Protocol
AnnouncementREG - Hemogenyx Pharma Plc - AGM Correction
AnnouncementREG - Hemogenyx Pharma Plc - Placing to Raise £451,250 and Director’s Dealing
AnnouncementREG - Hemogenyx Pharma Plc - Notice of AGM
AnnouncementREG - Hemogenyx Pharma Plc - Second Patient Treated with HG-CT-1 CAR-T Therapy
AnnouncementREG - Hemogenyx Pharma Plc - Final Results
AnnouncementRCS - Hemogenyx Pharma Plc - FDA Annual Report
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Hemogenyx Pharma Plc - First Patient Safety
AnnouncementREG - Stock Exch Notice - Admission to Trading - 18/03/2025
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Hemogenyx Pharma Plc - Recruitment of Second Patient for Clinical Trials
AnnouncementREG - Stock Exch Notice - Admission to Trading - 14/03/2025
Announcement